11/18/2020, 3:24 PM (Source: TeleTrader)
more TeleTrader news

Global vaccination doable in 2021 - CureVac CEO

CureVac CEO Franz-Werner Haas expressed optimism regarding the production of the COVID-19 vaccine on Wednesday, claiming it is possible for thepharmaceutical companies to produce enough doses to vaccinate the world's population by the end of 2021.

CureVac has unveiled earlier this week that it plans to manufacture some 300 million doses of its COVID-19 vaccine candidate by the end of 2021, and approximately double the figure the following year.

Haas has previously predicted that inoculation on a yearly basis probably won't be necessary, citing the company's research which allegedly found no mutations of COVID-19 similar to those observed in the seasonal flu.

Breaking the News / BU